Canadian Glaucoma Society

Emphasizing surgical glaucoma: Preservatives, trabeculectomy, IOP

Friday June 10, 2011, 1045-1215
Stanley Park 3

Objectives
At the end of this session, participants will be able to:

  • Express an understanding of preservative toxicity.
  • Identify factors that can alter intraocular pressure.


Guests
Eytan Blumenthal, MD
Dale Heuer, MD
Moderators
Frederick S. Mikelberg
Marcelo T. Nicolela
Robert M. Schertzer

1045Introduction: Preservative toxicity
1048Preservative exposure and surgical outcomes in glaucoma patients: The PESO study
Corey Boimer, Catherine Birt
1055Mechanisms of benzalkonium chloride toxicity in a human trabecular meshwork cell line
Cindy Hutnik, Angela Q. Zhang, Christopher Byrne, Grayson A. Roumelitis, Cindy Shao, Hong Liu
1102Discussion: Preservative toxicity papers
1108Introduction: Trabeculectomy surgical mini-symposium
1110Insights on glaucoma surgery and far beyond
Eytan Blumenthal
1120Critical look at trabeculectomy
Eytan Blumenthal, Dale Heuer, Robert M.Schertzer, CGS member contributors Free papers: IOP
1145Comparison of pre- and post-surgical intraocular pressure control in patients with corneal edema who have undergone DSAEK with patients who have undergone PKP
Lulu L. Bursztyn, Elizabeth Golesic, Rookaya Mather, David Tingey
1152The effect of beclomethasone nasal spray on intraocular pressure in ocular hypertension or controlled glaucoma
Darana Yuen, Yvonne M. Buys, Tariq Alasbali, Yaping Jin, Graham Trope
1159Early effects of Laser Peripheral Iridotomy (LPI) on intraocular pressure (IOP) in Primary Angle Closure Suspects (PACS) and Primary Angle Closure Glaucoma (PACG) patients
Nir Shoham, Gyanesh Verma, Mahmoud F. Rateb, Brian J. Chan, Garfield Miller, Iqbal Ike K. Ahmed
1206Discussion: Free papers IOP

Emphasizing surgical glaucoma: Tube-shunts and glaucoma risk factors

Friday June 10, 2011, 1330-1500
Stanley Park 3

Objectives
At the end of this session, participants will be able to:

  • Compare and contrast different techniques for trabeculectomy and tube-shunt surgeries (Ahmed and Baerveldt implants).
  • Describe the clinical and demographic factors of glaucoma development and progression.


Guests
Eytan Blumenthal, MD
Dale Heuer, MD
Moderator
Marcelo T. Nicolela

1330Introduction: Glaucoma tube-shunt free papers and surgical mini-symposium
1332The Ahmed versus Baerveldt (AVB) study: 2-year results
Panos G. Christakis, David Zurakowski, James C. Tsai, Jeffrey W. Kalenak, Jeffrey A. Kammer, Louis B. Cantor, Paul Harasymowycz, Iqbal Ike K. Ahmed
1339Modified techniques of Baerveldt implantation: Comparison with Ahmed drainage implant in the early post-operative phase
Toby Chan, David Tingey
1346Buccal mucous membrane grafts combined with corneal lamellar patch grafts for the repair of eroded glaucoma drainage devices: Mid-term outcomes in a large series
Stephanie A. Low, Dan B. Rootman, Graham Trope, David S. Rootman
1352Comparison of glaucoma drainage devices with combined cataract extraction
Simran S. Takhar, Nir Shoham, Panos Christakis, Iqbal Ike K Ahmed
1359Introduction: Tube-shunt surgical mini-symposium
1402Critical look at Ahmed & Baerveldt device implantation
Robert M. Schertzer, David Tingey, Dale Heuer, Eytan Blumenthal, CGS member contributors
Risk factors for glaucoma development and progression; new laser lens design
1422Does IOP reduction reduce the risk of development or progression of glaucoma?
Dale Heuer
1432Clinical and demographic risk factors for primary open angle glaucoma: A systematic review and meta-analysis
Hussein Hollands, Davin Johnson, Simon Hollands, Delan Jinapriya, Sanjay Sharma
1439Improving upon lens design for glaucoma laser procedures
Eytan Blumenthal
1449Discussion

Emphasizing surgical glaucoma: Ancillary testing, new glaucoma devices and techniques

Friday June 10, 2011, 1545-1715
Stanley Park 3


Guests
Eytan Blumenthal, MD
Dale Heuer, MD
Moderator
Fred S. Mikelberg

Objectives
At the end of this session, participants will be able to:

  • Outline patterns of visual field changes.
  • Discuss the accuracy of imaging modalities for glaucoma.
  • Discuss the evidence for new surgical devices and techniques and determine their relevance to practice.
  • Discuss techniques to help improve surgical success.
1545Introduction: Free papers on ancillary testing
1547Rates of global visual field change before and after trabeculectomy
Majed Alotaibi, Paul H. Artes, Macelo T. Nicolela
1554The diagnostic accuracy of flicker defined form perimetry, confocal laser scanning tomography, and frequency doubling technology perimetry in glaucoma detection
Ziad Butty, John G. Flanagan, Ayako Anraku, Delan Jinapriya, Yaping Jin, Graham Trope
1601Peripapillary choroidal thickness in glaucoma patients with focal, diffuse, and sclerotic optic disc damage, and in healthy controls
Kenneth F. Roberts, Paul H. Artes, Glen Sharpe, Alexandre S. Reis, Marcelo T. Nicolela
1608Summary of glaucoma testing accuracy: A comprehensive systematic review of clinical studies assessing heterogeneity
William G. Hodge, Zainab Khan, Kevin Warrian, Francie Si, Cindy Hutnik, Alex Mao, Irene Pan, David Moher, Ron Goeree, Fatemeh Yazdi, David Tingey
1615Discussion: Free papers on ancillary testing
1627Introduction: New devices free papers and rationale for their use
1629Cost analysis of Ex-PRESS ™ miniature glaucoma shunt versus trabeculectomy
Hussain Y. Patel, Lilach Wagschal, Graham Trope, Yvonne M. Buys
1636Comparison of the efficacy and safety of Ex-PRESS™ shunt implanted under scleral flap versus trabeculectomy: A prospective randomized study, interim results
Lilach Drori Wagschal, Graham Trope, Delan Jinapriya, Yvonne M. Buys
1643Discussion: Ex-PRESS™ shunt free papers
1649New devices and techniques for glaucoma surgery
iStent: Iqbal Ike K. Ahmed
Ex-PRESS™ mini-shunt: Yvonne M. Buys
Canaloplasty: Robert Schertzer
Trabectome: Karim Damji
1655New devices and techniques: Literature and cost-effectiveness
Dale Heuer
1705Discussion: New devices
1715CGS BUSINESS MEETING (members only)

COS-7 Glaucoma challenges in daily practice

Free papers, case discussion and current medical regimen on everyday issues in glaucoma

Saturday June 11, 1330-1500
Stanley Park 1&2


Guests
Eytan Blumenthal, MD
Dale Heuer, MD
Moderator
Yvonne M. Buys

Objectives
At the end of this session, participants will be able to:

  • Discuss the Canadian glaucoma guidelines, focusing on key issues such as how dilating pupils change IOP, the rate of change of glaucoma depending on the type of optic nerve, and the myth that ALT is better than SLT for raised IOP in pseudoexfoliation.
  • Describe the newer glaucoma medical therapies and where they fit into the treatment regimen.
  • Integrate into practice an effective approach for dealing with patients with persistent high IOP after laser iridotomy and a new patients presenting with very high IOP.
1330Introduction of free papers
1332Evaluation of the Canadian Glaucoma Guidelines: Results of a survey of Canadian Ophthalmologists
Enitan A. Sogbesan, Yvonne M. Buys, Paul E. Rafuse, Karim F. Damji
1339The effect of pharmacological pupillary dilation on intraocular pressure measurement using Goldmann applanation tonometry and hand-held transpalpebral tonometry
Cynthia Xin-ya Qian, Salima Hassanaly, Jean Duperré, Mona Harissi-Dagher
1346Rates of change in patients with glaucoma and different patterns of optic disc damage
Alexandre S. Reis, Paul H. Artes, Balwantray C. Chauhan, Marcelo T. Nicolela
1353A randomized prospective study of Selective Laser Trabeculoplasty vs Argon Laser Trabeculoplasty in open angle glaucoma and ocular hypertension due to pseudoexfoliation syndrome
Shefalee S. Kent, Cindy Hutnik, Catherine Birt, Karim F. Damji, Paul Harasymowycz, Andrew Crichton
1400DISCUSSION OF FREE PAPERS
1412Where do the new medications fit in our treatment of glaucoma?
Fred S. Mikelberg
1420Discussion
Fred S. Mikelberg, Iqbal Ike K. Ahmed, Catherine Birt, Dale Heuer, Eytan Blumenthal
1430Interactive case discussion: Uncontrolled IOP after laser iridotomy
Catherine Birt
1445Interactive case discussion: 14 y.o. with IOP of 35mm Hg
Iqbal Ike K. Ahmed
1500BREAK


Eytan Blumenthal MD


Dale Heuer, MD